SUN PHARMACEUTICAL IND LPembelian
Long
The stock is approximately 56.9% undervalued relative to its intrinsic value of 4,137.50, suggesting a significant buying opportunity at the current price of 1,783.
Based on technical analysis and market trends, a correction to around 1,600 to 1,400 could be an ideal buy zone, offering even greater upside potential for investors looking to enter at a discounted price. However, starting to accumulate shares at 1,783 could still provide a strong entry point for those with a long-term horizon
Based on technical analysis and market trends, a correction to around 1,600 to 1,400 could be an ideal buy zone, offering even greater upside potential for investors looking to enter at a discounted price. However, starting to accumulate shares at 1,783 could still provide a strong entry point for those with a long-term horizon
DO WHAT OTHERS DON"T KNOW AND DON'T DO WHAT OTHERS KNOW
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.